Skip to content

Cardioprotective Potential of the Ethanol and Water Extracts of Four Psilocybin Mushrooms on Angiotensin II-Induced Hypertrophy and Oxidative Stress on H9C2 Cardiomyocytes

Sanah Malomile Nkadimeng, Christiaan M.l. Steinmann, J.n. Eloff

Preprints.org June 6, 2023 preprint DOI: 10.20944/preprints202306.0362.v1 via OpenAlex

Summary

AI-generated from the abstract

Extracts from four psilocybin-containing mushrooms—Panaeolus cyanescens, Psilocybe natalensis, Psilocybe cubensis, and Psilocybe cubensis leucistic A+ strain—did not worsen angiotensin II-induced cardiac hypertrophy in rat heart cells and instead showed protective effects against oxidative stress. Angiotensin II reduced cell viability, increased cell width, and raised reactive oxygen species levels. The mushroom extracts, prepared with ethanol, cold water, or hot water, did not exacerbate these changes; they exhibited cardio-protective activity. Losartan, an angiotensin receptor blocker, served as a positive control. Phytochemical analysis detected known antioxidant and anti-inflammatory compounds in the extracts.

Study at a glance

Characteristics In vitro experimental study
Population H9C2 rat cardiomyoblast cells
Interventions 70% ethanol Psilocybe natalensis Psilocybe cubensis and Psilocybe cubensis leucistic A+ strain mushrooms
Duration 48 hours
Keywords Angiotensin ii Oxidative stress Losartan Reactive oxygen species Chemistry
Citations 1
Key finding Ethanol and water extracts of four psilocybin mushrooms did not exacerbate angiotensin II-induced hypertrophy and had cardio-protective activity against angiotensin II-induced oxidative stress.

Abstract

Psilocybin-containing mushrooms, commonly known as magic mushrooms have antidepressant effect, however, their safety in cardiovascular diseases such as heart failure is not fully known and needs to be investigated. Cardiac hypertrophy is an independent risk factor for heart failure morbidity and mortality. Angiotensin II (Ang-II) plays a major role in the pathogenesis of cardiac hypertrophy. We investigated the cardiovascular safety of extracts of Panaeolus cyanescens, Psilocybe natalensis, Psilocybe cubensis, and Psilocybe cubensis leucistic A+ strain mushrooms, well-known psilocybin-containing mushrooms in the Panaeolus and Psilocybe genus on Ang II-induced hypertrophy oxidative stress. The four mushrooms were grown, dried and extracted with 70% ethanol, cold and hot water. Extracts were tested for cytotoxicity on H9C2 cardiomyoblast cells. The cardiomyocytes were induced with (10 µM) AngII and treated with the three extracts of the four mushrooms over 48 hours. Control cells were serum starved but neither AngII induced nor treated while AngII cells were serum starved and stimulated with AngII but not treated. Losartan, an inhibitor of AngII type 1 receptor was used as positive control. Effects of the extracts on actin-filament labelling and cell surface area, mitochondrial activity, reactive oxygen species (ROS) and atrial natriuretic peptide levels were determined. Stimulation with AngII lowered cell viability, increased the cell width measurements and intracellular ROS levels significantly compared to control cells. The results indicated that the ethanol and water extracts of the four psilocybin mushrooms did not exacerbate the angiotensin II-induced hypertrophy conditions, but the extracts had cardio-protective activity against angiotensin II-induced oxidative stress. The phytochemical analysis of the extracts confirmed detections of known compounds with antioxidant and anti-inflammatory effects in the water and ethanol extracts of these four psilocybin mushrooms.

Comments

No comments yet.

Log in to comment